Scientists of reputed research institutions of the country have found AYUSH-64, a polyherbal formulation, helpful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care, the government said on Friday.
In a written response to a question in Lok Sabha, Minister of State for AYUSH Dr Mahendra Munjapara said the Ministry of Ayush-Council of Scientific and Industrial Research (CSIR) collaboration has recently completed a robust multi-centre clinical trial to evaluate the safety and efficacy of AYUSH-64 in the management of mild to moderate COVID-19 patients.
He said AYUSH-64 has been repurposed for the management of asymptomatic and mild to moderate cases of COVID-19 and has been recommended in the National Clinical Management Protocol based on Ayurveda and Yoga for the management of COVID-19.
"Further, Kabasur Kudineer, a Siddha preparation was also subjected to clinical trials to study the efficacy in COVID-19 patients by Central Council for Research in Siddha (CCRS) under Ministry of AYUSH also found useful in the treatment of mild to moderate COVID-19 infection," he said in his reply.
The minister said in order to provide the maximum benefits of Ayush systems of medicine, a nationwide campaign for distribution of AYUSH-64 and Kabasura Kudineer has been started.
"The scientists of reputed research institutions of the country have found that AYUSH-64, a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, is helpful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care," he said.
Responding to another question, he said during the second outbreak of COVID-19 in India, the Ministry of AYUSH has also launched a nationwide campaign through its research councils and national institute for mass distribution of AYUSH-64 to asymptomatic and mild to moderate COVID-19 patients in home isolation.
"Further, the technology of Ayush-64 has been transferred to 29 Ayush pharmaceutical manufacturing units for repurposing for COVID-19," he added.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Dominica To Award Its Highest National Honour To PM Modi Tuberculosis Replaces Covid As Top Infectious Disease Killer, Says WHO What Is A Tripledemic? Lookout For These Three Viruses That Cause Severe Respiratory Health Issues Live Updates: BJP+ Ahead In Maharashtra, Tight Race In Jharkhand, Predict Exit Polls Savage Attack On Andhra Pradesh College Student, Attackers Bit His Cheek NDA Has Edge In Maharashtra But 3 Of 9 Exit Polls Predict Hung Assembly Johnson & Johnson Risks UK Lawsuit Over Powder Cancer Claim By Thousands Sharad Pawar NCP's Worker Assaulted, Polling Booth Vandalised In Maharashtra Every Family In Delhi-NCR Has Pollution-Related Health Issues: Survey Track Latest News Live on NDTV.com and get news updates from India and around the world.